Hepatocellular adenomas

Liver International

Volumn 29, Issue 1, 2009, Pages 142-

  Bioulac Sage, Paulette ^a   Laumonier, Herv ^a   Sa Cunha, Antonio ^a   Balabaud, Charles ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; ORAL CONTRACEPTIVE AGENT; STEROID;

ARTIFICIAL EMBOLISM; GENE MUTATION; HEMOPERITONEUM; HUMAN; LETTER; LIVER ADENOMA; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; OBESITY; PATIENT SELECTION; RADIOFREQUENCY ABLATION; TUMOR BLEEDING; TUMOR VOLUME;

ADENOMA, LIVER CELL; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; HEMORRHAGE; HUMANS; RISK FACTORS;

EID: 57749182440     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01884.x     Document Type: Letter

References (7)

1. Veteläinen R, Erdogan D, de Graaf W, et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008; 28: 499-508.
2. van der Windt DJ, Kok NF, Hussain SM, et al. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006; 93: 1495-502.
3. Barthelmes L, Tait IS. Liver cell adenoma and liver cell adenomatosis. Hepato Pancreato Biliary Assoc 2005; 7: 186-96.
4. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48: 163-70.
5. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007; 46: 740-8.
6. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: MRI features as a function of molecular pathological classification. Hepatology 2008; 48: 808-18.
7. van der Windt DJ, Kok NF, Hussain SM, et al. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006; 93: 1495-502.